JPRN-jRCT2052230034进行中（未招募）2 期
An exploratory investigator-initiated trial on the safety and efficacy of ALARM-TD-V1 for sleep-disordered breathing - ALARM trial
Sato Susumu0 个研究点目标入组 40 人开始时间: 2023年6月8日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 90age old（—）
- 性别
- All
入选标准
- •Patients who meet all of the following inclusion criteria are eligible.
- •1) Patients aged between 18 and 90 at the time of informed consent
- •2) Patients who may be indicated for treatment obstructive sleep apnea syndrome, whose oxygen desaturation index (ODI) exceeds 5 times/hour based on 3% or Patients with obstructive sleep apnea syndrome who are on CPAP therapy and consent to discontinue CPAP 7 days before Day1(including patients who have received CPAP therapy even once in the past 5 years)
- •3) Patients without hearing impairment: Specifically, they must be able to recognize low-frequency sounds emitted from speakers without wearing hearing aids (implantable hearing aids can be worn). Specifically, the speaker should be placed 50 cm away from the head and the sound should be audible. (Similar to the hearing test, the test is conducted by asking participants to raise their hand when they hear a sound. The sound must be played twice. When the sound is heard, the hand must be raised in succession. Those who cannot answer correctly twice in a row are excluded. becomes)
- •4) Patients who have given written informed consent
排除标准
- •Patients meeting any one of the following exclusion criteria are not eligible.
- •1) Patients with a cardiac pacemaker
- •2) Patients wearing prostheses
- •3) Patients with fatal arrhythmia (except when the symptoms are stable due to pacemaker or ICD (implantable cardioverter-defibrillator) placement or drug treatment)
- •4) Patients with severe cardiac dysfunction or symptoms of heart failure (NYHA class II or higher)
- •5) Patients with a BMI greater than 32
- •6) Patients taking drugs that may alter consciousness, breathing pattern, or sleep structure (see 7.2 Concomitant drugs)
- •7) Pregnant women, women who may be pregnant, or women who do not intend to use contraception from obtaining consent until the end of the study period
- •8) Patients participating in other clinical trials
- •9) Other patients judged to be inappropriate by the investigator or subinvestigator
研究者
相似试验
招募中
2 期
An investigator-initiated trial to investigate the utility of LUNAR-1 in colorectal cancer patients with resectable distant metastasespatients scheduled for curative resection for metastasis of colorectal cancerctDNA, colorectal cancer, oligometastasisD015179JPRN-jRCT2072220055Oki Eiji160
已完成
不适用
An investigator-initiated clinical research on the ability of an electroencephalogram analysis program to differentiate between dementia with Lewy bodies (DLB) and Alzheimer's disease (AD)JPRN-UMIN000035926Department of Behavioral Neurology and Neuropsychiatry, Osaka University United Graduate School of Child Development40
进行中（未招募）
1 期
Investigator-initiated clinical research trial on the effects of 5% Minoxidil topical foam on gene expression, hair growth and scalp microenvironment in men with androgenetic alopeciaAndrogenetic Alopecia Hamilton-Norwood IIIv-IV male patientsMedDRA version: 16.1Level: PTClassification code 10068168Term: Androgenetic alopeciaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2013-004130-15-DECharité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science12
招募中
2 期
An exploratory randomized controlled trial of the clinical efficacy of anamorelin hydrochloride in patients after radical surgery for upper gastric cancer and esophagogastric junction cancer - a phase II trialGastric cancer, Esophagogastric junction cancerJPRN-jRCTs031230646Matsumoto Yasunori30
已完成
2 期
A clinical trial of a novel skin reconstruction treatment for GCMN.Congenital giant melanocytic nevusJPRN-jRCT2052210044Morimoto Naoki3